Target intelligence / Profile preview

Solute carrier family 1 member 5 mRNA 3' untranslated region (SLC1A5 mRNA 3'UTR) (SLC1A5 mRNA 3'UTR)

Target
SLC1A5 mRNA 3'UTR
Molecular classification
RNA, Untranslated region, Regulatory element
01

Overview

The Solute carrier family 1 member 5 (SLC1A5) mRNA 3' untranslated region (3'UTR) is a critical regulatory segment of the messenger RNA encoding the ASCT2 protein, a primary transporter for glutamine (PMID: 29343437). In many malignancies, SLC1A5 is overexpressed to meet the high metabolic demand for glutamine, a phenomenon known as glutamine addiction (PMID: 30104711). The 3'UTR contains specific binding sites for microRNAs (miRNAs) such as miR-137 and miR-122, which control the stability and translation efficiency of the SLC1A5 transcript (PMID: 28656230, PMID: 25605236). Therapeutic strategies targeting this region, such as miRNA mimics or antisense oligonucleotides, aim to downregulate SLC1A5 expression, thereby starving cancer cells of essential nutrients and inhibiting tumor progression (PMID: 31439341). Because SLC1A5 is a key driver of metabolic reprogramming in cancer, its mRNA 3'UTR represents a promising target for precision oncology and RNA-targeted drug development (UniProt P43007).

Other names
ASCT2 mRNA 3'UTRNeutral amino acid transporter B(0) mRNA 3'UTRSLC1A5 3'-untranslated regionATB(0) mRNA 3'UTR
02

Mechanism of action

Binding to the 3' untranslated region to induce mRNA degradation or inhibit translation, thereby reducing the expression of the SLC1A5 protein and limiting glutamine uptake in cancer cells.

03

Biological functions

Regulation of gene expressionmRNA stabilityTranslation regulationAmino acid transport regulation
04

Disease associations

CancerTriple-negative breast cancerNon-small cell lung cancerMelanomaColorectal cancer
05

Safety considerations

Off-target effects of RNA-based therapeuticsPotential impairment of normal amino acid transport in the gut and kidneysDelivery challenges to tumor sites
06

Interacting drugs

miR-137 mimics

3 more in the full profile.

07

Biomarkers

SLC1A5 protein expressionGlutamine uptake levels18F-glutamine PET imagingmiR-137 expression levels

Beyond the preview

Go deeper on Solute carrier family 1 member 5 mRNA 3' untranslated region (SLC1A5 mRNA 3'UTR) (SLC1A5 mRNA 3'UTR).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solute carrier family 1 member 5 mRNA 3' untranslated region (SLC1A5 mRNA 3'UTR) (SLC1A5 mRNA 3'UTR).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call